The planar cell polarity gene Vangl2 is required for mammalian kidney-branching morphogenesis and glomerular maturation by Yates, Laura et al.
The planar cell polarity gene Vangl2 is required
for mammalian kidney-branching morphogenesis
and glomerular maturation
Laura L. Yates1,{, Jenny Papakrivopoulou2,3,{, David A. Long2, Paraskevi Goggolidou1,
John O. Connolly3, Adrian S. Woolf4 and Charlotte H. Dean1,∗
1Mammalian Genetics Unit, Medical Research Council, Harwell, Oxfordshire OX11 0RD, UK, 2Nephro-Urology Unit,
UCL Institute of Child Health, London, UK, 3UCL Centre for Nephrology, Royal Free and University College Medical
School, London, UK and 4University of Manchester and Royal Manchester Children’s Hospital, Manchester, UK
Received July 28, 2010; Revised and Accepted September 8, 2010
The planar cell polarity (PCP) pathway, incorporating non-canonical Wnt signalling, controls embryonic con-
vergent (CE) extension, polarized cell division and ciliary orientation. It also limits diameters of differentiating
renal tubules, with mutation of certain components of the pathway causing cystic kidneys. Mutations in
mouse Vangl genes encoding core PCP proteins cause neural tube defects (NTDs) and Vangl2 mutations
also impair branching of embryonic mouse lung airways. Embryonic metanephric kidneys also undergo
branching morphogenesis and Vangl2 is known to be expressed in ureteric bud/collecting duct and meta-
nephric mesenchymal/nephron lineages. These observations led us to investigate metanephroi in Vangl2
mutant mice, Loop-tail (Lp). Although ureteric bud formation is normal in Vangl2Lp/Lp embryos, subsequent
in vivo and in vitro branching morphogenesis is impaired. Null mutant kidneys are short, consistent with a CE
defect. Differentiating glomerular epithelia express several PCP genes (Vangl1/2, Celsr1, Scrib, Mpk1/2 and
Fat4) and glomeruli in Vangl2Lp/Lp fetuses are smaller and contain less prominent capillary loops than
wild-type littermates. Furthermore, Vangl2Lp/1 kidneys had modest reduction in glomerular numbers postna-
tally. Vangl2Lp/Lp metanephroi contained occasional dilated tubules but no overt cystic phenotype. These
data show for the first time that a PCP gene is required for normal morphogenesis of both the ureteric
bud and metanephric mesenchyme-derived structures. It has long been recognized that certain individuals
with NTDs are born with malformed kidneys, and recent studies have discovered VANGL mutations in
some NTD patients. On the basis of our mutant mouse study, we suggest that PCP pathway mutations
should be sought when NTD and renal malformation co-exist.
INTRODUCTION
The planar cell polarity (PCP) pathway, incorporating non-
canonical Wnt signalling (1,2), directs embryonic convergent
(CE) extension, polarized cell division and cell differentiation
and also orientates cilia (3–6). Vangl (Van Gough/Strabismus)
genes code for core PCP proteins. The transmembrane protein
Vangl2 is expressed in the embryonic neural tube (7) and the
mouse Loop-tail (Lp) allele comprises a Vangl2 mutation
which encodes an unstable and mislocalized, and thus
non-functional, protein product (8,9). The mutation is ‘semi-
dominant’ with heterozygous mice being overtly healthy but
characterized by their malformed tails; Vangl2Lp/Lp,
however, causes a severe neural tube defect (NTD) called cra-
niorachischisis (10). In this context, the normal function of
Vangl2 is to facilitate, via Rho kinase (ROCK) and cyto-
skeletal rearrangement, cell-autonomous CE in axial meso-
derm and neuroepithelium before neurulation (11). Vangl1gt/
Vangl2Lp compound heterozygous mice have severe NTDs
(12) and subsets of individuals born with NTDs have been
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reported to have either VANGL1 or VANGL2 variants (13–16)
which may lead to dysfunctional gene products and thus con-
tribute to the pathogenesis of neural defects (17). Genetic
experiments in mice and zebrafish have shown that Vangl2
functions together with centrosomal/basal body-associated
proteins, mutated in the Bardet–Beidl (18) and oral facial
digital (19) syndromes, to drive embryonic CE. Furthermore,
Vangl2 directs the orientation of primary cilia, thus allowing
them to function optimally (5,6,20).
The embryonic precursor of the metanephros, which differ-
entiates into the mature mammalian kidney, initiates around
the fifth week of human gestation and embryonic day 11
(E11) in mice (21,22). The first phase of its morphogenesis
is dominated by epithelial branching, starting with the out-
growth of the ureteric bud from the mesonephric duct, fol-
lowed by arborization of the bud into the collecting ducts
which drain forming urine into the renal pelvis from where
it enters the ureter (21). Near the branching tips, metanephric
mesenchyme converts into another epithelium, the nephron
vesicle, which subsequently segments, elongates and differen-
tiates into components including the glomerular podocytes,
cells involved in ultrafiltration of blood in the first step of
urine production (23,24), and the proximal tubules featuring
actin-rich apical brush borders (25) which modify the ultrafil-
trate by reabsorption of specific molecules.
The embryonic lung is another organ which forms by
branching morphogenesis, and we recently reported that
Vangl2Lp/Lp mice have defective embryonic lung airway
branching (26). Lung branching was also perturbed in Crash
mice which have mutation of cadherin EGF LAG seven pass
G-type receptor 1/Flamingo (Celsr1), another gene encoding
a PCP protein (26). Intriguingly, in murine developing
kidneys, Vangl2 protein is known to be expressed in ureteric
bud epithelia (7) and in fetal podocytes (27). Although the
exact pattern of branching is different in kidneys and lungs,
the above observations led us to hypothesize that Vangl2
may have roles in kidney-branching morphogenesis and
perhaps glomerular maturation. On the basis of the results of
our current Vangl2 mutant mouse study, which indeed show
that this PCP component is required for normal kidney mor-
phogenesis, we suggest that VANGL mutations should
especially be sought in humans who are found to have both
an NTD and a malformed renal tract (28–30).
RESULTS
Branching morphogenesis is disrupted in Vangl2Lp
kidneys in vivo and in vitro
To determine whether kidney development was affected by
Vangl2 mutation, we first examined the anatomical initiation
of the metanephros. In transverse sections of both wild-type
and Vangl2Lp/Lp E11.5 embryos, we observed paired meta-
nephric rudiments, each with a ureteric bud surrounded by
mesenchymal cells (Fig. 1A and B). By E13.5, the normal
ureteric bud has branched several times (21,22). Whole-mount
immunostaining for cytokeratin was undertaken (Fig. 1C and
D) to visualize both branching tips and collecting duct stalks
(31). E13.5 wild-type organs contained significantly more ure-
teric bud branch tips than either heterozygous or homozygous
Vangl2 mutant E13.5 metanephroi (Fig. 1E). None of the
several tens of mutant embryos examined between E11 and
late gestation had other ureteric defects such as duplication
or dilatation (data not shown). We noted that both at E13.5
and in later gestation (E18.5) Vangl2Lp/lp kidneys appeared
smaller compared with wild-type littermates, especially in
their antero-posterior axis (Fig. 1C, D and F). In fact, homozy-
gous mutant E18.5 kidneys had a significantly (P, 0.01)
lower length/width ratio (mean+SEM; 1.48+ 0.02, n ¼ 3)
than wild-type organs (1.74+ 0.02, n ¼ 3). Vangl2Lp/Lp
embryos are known to have a shortened rostrocaudal axis,
and this has been attributed to a primary CE defect (11).
Thus, a trivial explanation for the small mutant metanephroi
would be that, in vivo, an abnormally shaped embryonic
body might have physically constrained their morphogenesis.
We therefore isolated late E11.5 metanephroi and followed
their progress in serum-free organ culture (32). After 2 days,
wild-type organs had undergone marked growth (Fig. 1G)
whereas, in comparison, the progress of Vangl2Lp/Lp organs
appeared retarded to variable degrees (Fig. 1H and I). At
this stage, wild-types had significantly more ureteric bud
branch tips versus Vangl2Lp/Lp organs (Fig. 1J). In other exper-
iments, E12 organs, in which the bud had branched once, were
cultured for 5 days and then co-immunostained for cytokera-
tin, to highlight the ureteric bud lineage, and Wilms tumour
1 (WT-1), to highlight glomerular podocytes (33) (Fig. 1K
and L). At the end of the observation period, Vangl2Lp/Lp
organs always appeared smaller than wild-type metanephroi
(Fig. 1K and L). Mutant kidneys in vitro contained branch
tips which frequently appeared distorted and wider than
normal (compare Fig. 1 inserts in C and D and also frames
K and L); we have previously noted a similar phenotype in
the lungs of Vangl2Lp/Lp mice (26). Cultured organs from
both genotypes contained clusters of WT-1-expressing cells,
indicating that lack of Vangl2 function did not block for-
mation of glomeruli in vitro (Fig. 1K and L). The detailed
effects of Vangl2 mutation on glomerular maturation in vivo
are explored below.
The late-gestation Vangl2Lp/Lp kidney has poor
cortico-medullary definition, a hypoplastic medulla
and mildly dysmorphic tubules
At E14.5, homozygous mutant metanephroi appeared smaller
than those of wild-types (Fig. 2A–C). Inside E14.5
Vangl2Lp/+ and Vangl2Lp/Lp organs, as in wild-type littermate
metanephroi, condensing renal mesenchyme was visualized
around ureteric bud branch tips, and adjacent nephron vesicles
were apparent (Fig. 2D–F). Despite the smaller size of E14.5
organs, both proliferation and apoptosis measured in situ
across the whole metanephros was similar in wild-type and
Vangl2Lp/Lp organs (Fig. 2G–P). By E18.5, the wild-type
metanephros had undergone further growth and acquired its
characteristic ‘kidney bean shape’, and its centre was occupied
by a slit-like renal pelvis, the cavity which receives urine from
the collecting duct system (Fig. 3A). Overall histology of
E18.5 Vangl2Lp/+ kidneys (Fig. 3B) appeared similar to their
wild-type counterparts, whereas Vangl2Lp/Lp E18.5 kidneys
lacked the normal curved profile and contained a renal
pelvis which resembled a hole rather than the normal
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elongated cavity (compare the outline of the organ in Fig. 3C
with A). At this stage, the wild-type kidney contained a well-
demarcated cortex and medulla (Fig. 3D). The outer cortex
comprised ureteric bud branch tips whereas the cortex below
this contained S-shaped bodies, which are immature nephrons
beginning to segment into glomerular and proximal tubule
epithelia (Fig. 4A–D), as well as proximal tubules and glo-
meruli (Figs 3D, G, 4E and F). The demarcation between
the cortex and medulla was unclear in Vangl2Lp/Lp organs
(Fig. 3F), with heterozygous kidneys (Fig. 3E) having an inter-
mediate appearance between null mutant and wild-type litter-
mates. Whereas proximal tubules and glomeruli appeared
grossly normal in Vangl2Lp/+ organs (compare Fig. 3H with
G), homozygous mutant kidneys contained subsets of glomer-
uli which were small or distorted (a feature examined in detail
below) and some tubules contained attenuated brush borders
as visualized by periodic-acidSchiff (PAS) staining (Fig. 3I).
The brush border of a differentiated proximal tubule cell
comprises microvilli inserting into the apical zone of the epi-
thelium, and both zones are rich in actin (25). Using phalloidin
staining to visualize the f-actin cytoskeleton, some proximal
tubule profiles in E18.5 Vangl2Lp/Lp kidneys had an irregular
and discontinuous actin pattern versus proximal tubules in
wild-type littermates (compare Fig. 3K with J). Although
some tubules in fetal null mutant kidneys appeared dilated
(Fig. 3I), an overt polycystic phenotype was not seen.
Several PCP molecules are expressed in the nephrogenic
cortex and in differentiating podocytes
Vangl2 protein has previously been immunodetected in devel-
oping murine kidneys in ureteric bud branch tips, collecting
ducts, nephron vesicles and forming glomeruli (S-shaped
bodies and podocyte epithelia) (7,27). Because the results of
Figure 1. Early branching morphogenesis is disrupted in Vangl2Lp kidneys in
vivo and in vitro. Haematoxylin- and eosin-stained transverse sections through
whole E11.5 embryos showed similar appearances in both wild-type (A) and
Vangl2Lp/Lp (B) littermate embryos (n ¼ 3 each genotype). Both had paired
metanephric rudiments in which the ureteric bud (UB) penetrated into meta-
nephric mesenchyme (MM). E13.5 whole z-stack images of wild-type (C)
and Vangl2Lp/Lp (D) kidneys immunostained for cytokeratin (green signal).
Inserts in (C) and (D) show representative zoomed-in images of typical ure-
teric bud tips; Vangl2Lp/Lp bud tips are frequently shorter and broader than
in wild-type. (E) There was a significant (P , 0.01) reduction in numbers
of ureteric bud branch tips in Vangl2Lp heterozygote (n ¼ 12) and homozygote
(n ¼ 5) versus wild-type (n ¼ 4) metanephroi. At E18.5, Vangl2Lp kidneys (F,
right) appeared smaller and abnormally shaped in comparison to wild-type lit-
termates (F, left). After 2days in culture, E11.5 mutant explants (H and I)
appeared variably growth-retarded versus wild-type organs (G). Furthermore,
these cultured Vangl2Lp/Lp metanephroi (n ¼ 10) had significantly (P ¼ 0.009)
fewer bud tips in comparison to wild-type littermates (n ¼ 7) (J). (K and L)
To assess potential further differentiation in vitro, E12.0 metanephroi were
cultured for 5 days and then immunostained for both cytokeratin (red) to high-
light the arborizing ureteric tree, and WT1 (green) to highlight podocytes
within glomeruli. After 5 days, wild-type explants (K; n ¼ 3) appeared con-
sistently larger than the Vangl2Lp/Lp organ (L; n ¼ 3). The ureteric tree in
mutants appeared distorted with wider branch tips. Balls of WT-1-expressing
cells, primitive glomeruli, formed in both genotypes. Scale bars: (A and B)
50 mM, (C and D) 125 mM, (F) 62.5 mM, (G–I) 63 mM and (K and L) 125 mM.
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those studies are clear, we did not attempt to replicate them
here. Instead, to gain a greater understanding of PCP
pathway components in kidney development, we examined
the distribution of Scribble 1 (Scrib), a protein mutated in
the Circletail mouse (34), and Celsr1, a molecule known to
be critical for lung branching (26). In wild-type E18.5
kidneys, which contain a spectrum of differentiating struc-
tures, Scrib was immunodetected (Fig. 4A, C and E) most
prominently in the outer (nephrogenic) cortex where ureteric
bud branch tips, mesenchymal condensates, vesicles and
S-shaped bodies expressed the protein. Maturing podocytes
were also positive. Celsr1 (Fig. 4B, D and F) was expressed
in the cortex of the E18.5 kidney where it was most prominent
in more mature components such as collecting duct stalks and
S-shaped bodies (Fig. 4D) rather than bud tips and vesicles.
Celsr1 was also detected in podocytes and adjacent proximal
Figure 2. E14.5 Loop-tail kidneys exhibit normal histology and no change in proliferation or apoptosis. Haematoxylin-stained sections of E14.5 wild-type (A and
D), Vangl2Lp/+ (B and E) and Vangl2Lp/Lp (C and F) metanephroi. At E14.5, although all three genotypes contained renal vesicles (RV) and ureteric bud branches
(UB), Vangl2Lp/Lp organs appeared smaller than wild-type littermates (compare C with A). Analysis of the percentage of proliferating cells in E14.5 whole kidney
sections by immunostaining with anti-pH3 (G, I and O) or of apoptosis with anti-cleaved caspase 3 (CC3) (K, M and P) and DAPI (H, J, L and N) revealed no
significant differences between wild-type (red) and Vangl2Lp/Lp (blue). Proliferation and apoptotic indices were, respectively, calculated by counting the numbers
of phosphor histone-H3 (PH3)- or cleaved caspase 3 (Cleaved Caspase)-expressing cells in kidney sections from three individuals of each genotype, and showing
them as a percentage of total (DAPI-stained) nuclei. Images are representative of at least three animals in each category. Scale bars: (A–C) ¼ 100 mM and (D–
F) ¼ 25 mM.
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tubules (Fig. 4F). No significant signal was obtained when
primary antibodies were omitted (Fig. 4G and H). Previous
studies have established the specificity of these antibodies by
attenuation and/or mislocalization of the Vangl2 protein in Lp/
Lp embryos and the Celsr1 protein in Crsh/Crsh embryos
(26,35,36). Finally, we used an established in vitro cell culture
system (37) to seek the expression of a panel of PCP genes in
both undifferentiated and differentiated mouse podocytes
(Fig. 5). The in vitro differentiation is characterized by a
change from proliferating cells with few processes, to quiescent
Figure 3. Histology of E18.5 kidneys. E18.5 (A–K) kidneys from wild-type (A, D, G and J), Vangl2Lp/+ (B, E and H) and Vangl2Lp/Lp (C, F, I and K) mice. At
E18.5, homozygous (C) kidneys appeared smaller than wild-type littermate kidneys (A). Vangl2Lp/Lp kidneys are visibly misshaped, with a hypoplastic medulla
(compare F with D) and the renal pelvis (∗) lacks the normal slit-like shape seen in wild-type and Vangl2Lp/+ kidneys (compare C with A and B). Occasional
enlarged and distorted proximal tubules with attenuated brush borders (pink) were observed in Vangl2Lp/Lp mice (I), but there was no overt cystic phenotype.
Phalloidin staining highlights disruption to the organization of the actin cytoskeleton in Vangl2Lp/Lp proximal tubules; particularly at the apical surface (K), in
comparison to the ordered cytoskeletal arrangement in Vangl2+/+(J). Images are representative of at least three animals in each category. c, cortex; g, glomer-
ulus; m, medulla; pt, proximal tubule. Scale bars: (A–C) ¼ 200 mM, (D–I) ¼ 25 mM and (J and K) ¼ 5 mM.
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cells with up to several actin-rich processes which grow from the
cell body (Fig. 5A and B). In both conditions (Fig. 5C and D),
podocytes expressed Vangl2 and well as Vangl1, Celsr1, Fat4,
mouse prickle1 and mouse prickle2 (mpk1 and mpk2; 38,39).
E18.5 Vangl2Lp/Lp kidneys show abnormalities
of glomerular maturation
The above observations prompted us to look closely at
forming glomeruli in E18.5 kidneys. We conducted a careful
analysis of glomerular morphology undertaken by an observer,
blinded as to the genotypes of the organs, who assigned at
least several tens of glomeruli in each kidney into one of
four categories, according to the extent of maturation or mor-
phological disruption, with ‘a’ being the most mature and ‘d’
being the most abnormal (Fig. 6A). In wild-type kidneys,
over 95% of glomerular cross-sections displayed two or
more capillary lumens (a marker of maturity), and most had
more than two such lumens (Fig. 6B). By contrast, in late-
gestation Vangl2Lp/Lp kidneys, ,90% of all glomeruli
contained two or more capillary lumens and, more strikingly,
only half of these had more than two lumens. Moreover, in the
null mutant kidneys, a small subset of glomeruli were mal-
formed, with a distorted glomerular tuft (subtype d); such pro-
files were never observed in several hundreds of glomeruli
scored in wild-type kidneys. The average diameter of
Vangl2Lp/Lp glomerular tufts (i.e. the central ball of cells
without the surrounding Bowman’s space and outer parietal
epithelium) was significantly less than in wild-type kidneys
(Fig. 6C). For Vangl2Lp/+ kidneys, values were intermediate
between wild-types and null mutants (Fig. 6B and C). We
also sought proliferating cells in glomerular tufts by an immu-
nohistochemical method (Fig. 6D) and found that the pro-
portion of positive nuclei was significantly reduced in
Vangl2Lp/Lp glomeruli versus either wild-type or Vangl2Lp/+
kidneys (Fig. 6E). When comparing the most mature-looking
glomeruli (i.e. subtype ‘a.’) in the three genotypes, immunos-
taining patterns for both synaptopodin, a molecule which regu-
lates podocyte actin dynamics (40), and nephrin, a component
of the junctions between podocyte foot processes (24),
Figure 4. PCP pathway components are expressed in E18.5 kidney. Immunostaining (brown) for Scrib (A, C and E) and Celsr1 (B, D and F) in E18.5 sections
(note there is no counterstain in these sections). Scrib expression was prominent in the outer (nephrogenic) cortex (c in A) where it was found in diverse struc-
tures such as ureteric bud tips, mesenchymal condensates and vesicles (C). Scrib was also expressed in maturing podocytes located in the periphery of the glo-
merular tuft (E). Celsr1 expression was noted in collecting duct stalks and S-shaped bodies just below the nephrogenic zone (B and D). Expression of Celsr1 was
also observed in proximal tubule and podocyte epithelia (F). Where primary antibodies were omitted, no significant staining was observed (G and H). Dashed
line in (G) marks edge of kidney; below line is tissue. c, cortex; g, glomerulus; m, medulla; pt, proximal tubule. Scale bars: (A and B) 100 mM, (C and D), (G)
25 mM and (E, F and H) 12.5 mM.
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appeared similar (Fig. 6D). As assessed by phalloidin staining,
the crenellated pattern of f-actin evident in wild-type glomer-
ular tufts, probably representing actin in both the basal zone of
podocytes and in closely adjacent endothelia in forming capil-
lary tufts (41), appeared less prominent in Vangl2Lp/Lp glomer-
uli (Fig. 6F).
Gene expression in E18.5 kidneys
To assess whether the various morphological aberrations
described above in E18.5 Vangl2Lp/Lp kidneys corresponded
to transcriptional changes, levels of transcripts were measured
by quantitative PCR (32) in RNA extracted from whole
organs. The genes analysed (Supplementary Material,
Table S1) included those coding for: (i) transcription factors,
growth factors/receptors and adhesion molecules implicated
in metanephric-branching morphogenesis and nephron
formation; (ii) proteins characteristically expressed by specific
differentiated epithelia within collecting ducts, glomeruli,
proximal tubules and loops of Henle; and (iii) ciliary/basal
body proteins, mutations of which cause polycystic kidney
disorders. Comparing levels of these mRNAs factored for
levels of housekeeping transcripts between wild-type and
Vangl2Lp/Lp organs, none were significantly different (i.e.
P , 0.05; data not shown). This analysis did, however,
suggest that levels of four genes (Shh, Patched 1, Fgf7 and
Ift88) tended to differ between the two genotypes. We there-
fore re-examined levels of these transcripts using an indepen-
dent set of qPCR assays on cDNA from additional embryos.
The results of these assays (Supplementary Material,
Fig. S1) failed to confirm the previously observed trends.
Postnatal Vangl2Lp/1 kidneys have a modest reduction
in glomerular numbers
As depicted in Figure 7 and data not shown, Vangl2Lp/+
kidneys of 1-month-old mice were found to have a modest
but significant deficit in glomerular numbers, although immu-
nostaining for synaptopodin and nephrin was normal, and
there was no sign of glomerulosclerosis (scarring) as assessed
by PAS staining (Fig. 7). Tubules showed no cyst formation.
Finally, we found no difference in urinary albumin (Fig. 7H)
or retinol-binding protein excretion (Fig. 7I) between
12-week-old wild-type and Vangl2Lp/+ mice. An increased
level of albumin would be expected if there existed significant
impairment of the glomerular permeability barrier (i.e. a podo-
cyte function). An increased level of retinol binding protein
would be expected if proximal tubule uptake of small mol-
ecules had been impaired.
DISCUSSION
PCP genes and kidney development
In the fetal kidney, the PCP pathway is considered to set a
limit on the diameter of differentiating tubules because
Wnt9b mutation causes cystic kidneys, perturbing the normal
CE-like rearrangement of existing epithelial cells during
tubule elongation and narrowing (42). Later in mouse kidney
maturation, tubule diameter is limited by a predominance of
polarized cell divisions aligned along the longitudinal axis
of the tubule (43). This, in turn, requires the function of
primary cilia (43), organelles which protrude from the apical
epithelial surface and which transduce signals triggered by
tubular fluid flow and perhaps also by yet-to-be defined com-
ponents in the fluid (44). Oriented cell divisions and tubule
elongation are disrupted by mutation of Fat4, a PCP gene,
the protein product of which is also detected in primary cilia
(44,45). Intriguingly, the cystic kidney phenotype observed
in Fat4 mutants is accentuated when mice are additionally hal-
poinsufficient for Vangl2 (45). Another link between renal
cysts, PCP and ciliary sensing is provided by inversin, a
protein mediating a switch from canonical to non-canonical
Wnt signalling (46). Expression of inversin is upregulated
by fluid flow, and Invs mutations lead to cystic kidneys (46).
In our current study, we failed to find a cystic phenotype
either in Vangl2Lp/Lp and Vangl2Lp/+ fetal kidneys or in
Figure 5. RT–PCR expression of PCP pathway components in mouse podo-
cytes. Phase-contrast micrographs of undifferentiated (A) and differentiated
podocytes (B) showing the extensive process formation characteristic of the
in vivo podocyte phenotype. Vangl1/2, Fat4, Celsr1 and Mpk1/2 transcripts
were identified in undifferentiated podocytes (C) but no statistically significant
(P , 0.05) differences in expression between undifferentiated and differen-
tiated cells were identified by quantitative real-time PCR (D). Results from
three independent experiments are shown. Scale bar, 25 mM.
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1-month-old Vangl2 heterozygous kidneys. It remains possible,
however, that the absence of Vangl2 might lead to cysts in the
weeks after birth and that Vangl2 haploinsufficiency might
cause kidney cysts later in adulthood. As assessed by PCR of
late-gestation kidneys, the Vangl2Lp/Lp mutation did not signifi-
cantly alter the expression of numerous transcripts (e.g. Bbs1/4,
Ift88, Invs, Mks1, Ofd1 and Pkd1/2), which encode ciliary pro-
teins implicated in genetic cystic kidney diseases. Furthermore,
we found that tubules in Vangl2Lp/Lp fetal kidneys did contain
primary cilia (data not shown), as assessed by immunostaining
for acetylated a-tubulin and IFT88 (19,47), although their
orientation or numbers were not formally assessed.
Figure 6. Disruption of Vangl2 causes glomerular maturation defects. All data in this figure are from E18.5 kidneys. Glomerular tuft morphology was assessed
according to the following categories: a, more than two capillary lumens per tuft; b, one or two capillary lumens; c, no capillary lumens; d, abnormal and dis-
rupted glomerular tuft. (A) Representative glomeruli in each category. (B) Proportions of glomeruli in the three genotypes (n ¼ 3–4 kidneys in each set). The
commonest phenotype of wild-type and heterozygous glomeruli was category a. Vangl2Lp/Lp glomeruli showed a shift of phenotypes such that glomerular types a
and b were equally common and they contained a small subset of category d never seen in wild-type kidneys. Vangl2Lp/Lp glomerular tufts had a significantly
reduced glomerular diameter (C). (Da–c) Proliferation of glomerular cells as assessed by immunodetection of PCNA (white nuclei). A reduction in the frequency
of proliferation in homozygous organs was confirmed upon counting proportions of proliferating cells in the glomerular tuft (E). (Dd–f). Synaptopodin (green)
and WT-1 (red) co-staining showed similar appearances in the three genotypes when mature glomeruli were assessed. (Dg–i) Nephrin (green) immunostaining
showed similar appearances in the three genotypes when mature glomeruli were assessed. (F) Phalloidin staining highlighted the typical crenellated pattern of
f-actin in Vangl2+/+ glomerulus (arrowed on the left frame) which appeared less apparent in a Vangl2Lp/Lp glomerulus (arrowed on the right frame). Counts were
performed on at least 20 glomeruli from at least three to four separate kidneys in each genotype. ∗P , 0.05 compared with wild-type; +P , 0.05 compared with
heterozygotes. Scale bars ¼ 15 mM.
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Despite the above insights into tubule diameter regulation,
the roles, if any, of the PCP pathway on other metanephric
processes, such as initiation of the kidney, ureter formation,
branching morphogenesis and glomerular morphogenesis,
have been unclear. We found that, at least in the C3H/HeH
background studied, Vangl2 deficiency did not prevent ure-
teric bud formation nor aggregation of intermediate mesoder-
mal cells, which together comprise the metanephric rudiment.
Nor did Vangl2 deficiency lead to ureteric duplication or
ureter dilatation, the latter structure derived from the distal
part of the ureteric bud.
Vangl2 is required for kidney-branching morphogenesis
Our data show that Vangl2 mutation strikingly impairs the
arborization of the ureteric tree and that it is also associated
with impaired glomerular maturation. This is the first
demonstration that a core PCP component is required for
normal development of both ureteric bud and metanephric
mesenchyme-derived structures. The fact that developing
epithelia in both lineages express Vangl2 protein is consistent
with intrinsic functions in ureteric bud branches and nascent
glomeruli (7, 27). Compared with time-matched wild-type
organs, the growth restriction observed in explanted Vangl2
null mutant E11.5 rudiments appeared more prominent than
that seen in either E12.0 explants or Vangl2 null mutant meta-
nephroi in vivo. One possible explanation is that the serum-free
tissue culture conditions used for such experiments may be
more ‘stressful’ for younger rudiments and that any additional
insult (in this case the Vangl2 mutation) results in a more
severe in vitro phenotype.
Our immunohistochemistry studies which localized the PCP
proteins Scrib and Celsr1 in diverse structures in the still-
developing outer cortex of the late-gestation kidney concur
with patterns of transcripts as reported in the Genito-Urinary
Development Molecular Anatomy Project database
[GUDMAP (48)]. We suggest that the branching impairment
found in both Vangl2Lp heterozygous and homozygous meta-
nephroi is an intrinsic defect operating within ureteric bud
epithelia. In a quantitative PCR survey, we found no signifi-
cant differences in levels of transcripts for growth factor sig-
nalling molecules (e.g. Areg, Bmp4, Egf, Fgf7, Hgf, Gdnf,
Tfga and Wnt11) which are known to regulate kidney branch-
ing (21). Instead, there are probably mechanistic parallels
between the defective branching we observed in Vangl2Lp
embryonic kidneys and the defects in lung branching reported
by Yates et al. (26) in Vangl2 mutant mice. This study showed
that branching defects were due to impaired tissue morphogen-
esis as a result of cytoskeletal disruption. In fact, the lung-
branching defect in these mutants could not be rescued in
vitro upon the addition of Fgf10, a growth factor that normally
induces lung branching (26).
More likely, Vangl2 mediates branching in both the lung
and kidney in a cell-autonomous manner acting, as it does in
neural tube closure (11), through ROCK-mediated cytoskeletal
actions. ROCK indirectly inhibits actin filament depolymeri-
zation (49), and when perturbed, over time, actin monomers
that are required to continue actin polymerization for
migration and cell movement become limited. Indeed, the
branching defects observed in Vangl2Lp/Lp lungs can be mod-
elled by chemical inhibition of this enzyme in organ culture of
wild-type embryonic lungs (26), and it is already established
that branching morphogenesis in the metanephros is sensitive
to ROCK activity (50–52). While we did not detect any
marked alteration in pattern of f-actin in Vangl2Lp/Lp ureteric
bud branch tips (data not shown), it was notable that the
apical f-actin pattern appeared irregular in mutant proximal-
like tubules. Future studies should use conditional deletion
Cre-LoxP strategies, for example using the ureteric
lineage-specific HoxB7/Cre line (53), to confirm the hypoth-
esis that the kidney-branching defect is caused by deficiency
of Vangl2 within arborizing epithelia.
Figure 7. Histology of adult Vangl2Lp/+ kidneys. (A and B) PAS staining of
4-week-old Vangl2Lp/+ mice kidneys show a normal appearance with no scar-
ring. Expression patterns of synaptopodin (green in C and D) and nephrin
(green in E and F) were similar in wild-type and heterozygous glomeruli.
(G) Reduced glomerular numbers per kidney in Vangl2Lp/+ mice (n ¼ 4)
versus wild-type littermates (n ¼ 4). No significant differences in the ratio
of urinary albumin/creatinine (H) or retinol-binding protein (RBP)/creatinine
(I) were found between Vangl2Lp/+ and Vangl2+/+ mice. Scale bars ¼ 15 mM.
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The retardation of metanephric-branching morphogenesis
which we measured in the first days of Vangl2Lp/Lp metaneph-
ric development likely explains why the late-gestation null-
mutant kidney has a poorly developed medulla and renal
pelvis because bud-derived collecting ducts normally populate
the medulla and contribute to the shape of the pelvis. As
assessed by qPCR, there were no differences between null
mutant and wild-type late-gestation kidneys in expression of
differentiation markers of specific tubule epithelia (e.g. Ggt1
for proximal tubules, Umod for loops of Henle and Aqp2 for
collecting ducts). These observations are consistent with the
idea that Vangl2 is not required for terminal differentiation
of tubules but instead modulates their morphogenesis.
Humans with NTDs sometimes also have
kidney malformations
Historically, individuals born with NTDs often died from renal
failure, which was perceived as arising from excessive back-
pressure on the kidneys from impaired urine flow combined
with bacterial infection ascending from urine pooled in poor-
emptying urinary bladders. Some individuals with NTDs,
however, are born with kidney malformations such as agenesis
(unilateral absent kidney), gross defects in renal shape (horse-
shoe kidney) and ureteric duplication (duplex kidneys) (28–
30). These historical clinical observations are consistent with
the idea that both the renal malformation and NTD arise
from common, perhaps genetic or environmental, causes. On
the basis of our observations in mice, we suggest that the
subset of individuals with NTDs who also have kidney malfor-
mations may be found to have VANGL or other PCP gene
mutations.
Vangl2 is required for kidney glomerular maturation
We also found that the tufts of glomeruli in Vangl2Lp/Lp late-
gestation kidneys were smaller than their wild-type litter-
mates. This was associated with a decrease in percentage of
proliferating cells within the tufts. Glomerular tufts initially
comprise only differentiating podocytes and they then
become invaded by blood capillary loops and pericyte-like
mesangial cells (23,54). Our methodology could not dis-
tinguish whether the proliferation defect in Vangl2Lp/Lp tufts
affected a specific type of cell although proliferation did
appear to be reduced in the periphery of the tuft (compare
null mutant with wild-type in Fig. 6D) where podocytes are
found. The cause of the proliferation defect is uncertain, but
we note that Vangl2 has been implicated in the expansion of
muscle (4) and neural (3) stem cells. In the latter example
(3), late-gestation Vangl2Lp/Lp brains showed a significant
reduction in dividing progenitors even though earlier in ges-
tation, exactly as found in E14.5 Vangl2 mutant metanephroi,
the numbers of proliferating cells were the same as in controls.
Thus, we speculate that Vangl2 may regulate the numbers of
glomerular precursor cells within the primitive nephron. Con-
sistent with this interpretation of the Vangl2Lp/Lp glomerular
tuft size in relation to podocyte proliferation, we found that
isolated differentiating podocytes express an array of PCP
transcripts, including Vangl2.
Podocytes are extremely plastic cells and as such they are
able to alter their shape via molecular regulation of their intra-
cellular cytoskeleton. Cytoskeletal disruption caused by injury
or genetic disorders of glomerular function leads to mis-
shaping or absence of foot processes (24,55). Unless this
process can be reversed, it results in leakage of protein into
the glomerular filtrate, glomerular scarring and eventually,
chronic renal failure. Therefore, an understanding of the mol-
ecular mechanisms regulating podocyte architecture is likely
to prove valuable for treatment of glomerular dysfunction.
Synaptopodin plays an essential role in the regulation of podo-
cyte actin dynamics and RhoA is a target of the molecule (40).
However, we noted no overt abnormality in the pattern of
synaptopodin protein in Vangl2 mutant glomeruli. In a
recent cell culture study, Babayeva et al. (27) reported that
siRNA depletion of podocyte Vangl2 reduced the number of
cell projections, decreased actin stress fibres and impaired
cell motility. How this result relates to the glomerular pheno-
type we observed in Vangl2Lp/Lp kidneys is not clear although
it provides proof of principle that Vangl2 plays an active role
in podocyte biology. Ichimura et al. (56) recently reported that
immature podocytes express primary cilia in vivo but that
these organelles are lost with full differentiation. In future, it
would be interesting to determine whether the Vangl2
protein can be found associated with these structures.
We note that endothelia in developing glomeruli have been
reported to express Vangl2 transcripts (48) and, if capillary
migration were to be compromised, this may help explain
why Vangl2Lp/Lp tufts have a deficit in capillary lumens. The
apparent attenuation of f-actin we observed in mutant fetal
glomeruli may represent a combined aberration in the cytoske-
leton of both podocytes and closely adjacent endothelia (41).
According to our current data and those from GUDMAP
(48), podocytes also express Vangl1 transcripts. Given the
fact that, in other tissues, there is genetic interaction
between Vangl1 and Vangl2 (12), we predict that double
mutants would have a much more severe glomerular pheno-
type than that displayed by Vangl2 mutants in the current
study. Finally, we note that upregulation of canonical Wnt/
b-catenin signalling has been implicated in the pathophysiol-
ogy of acquired proteinuric glomerular diseases (57). In
future, a definitive exploration of the roles of Wnt canonical
and non-canonical/PCP pathways in glomeruli genes will
require their selective deletion in these cells at different
stages of glomerular differentiation using Cre-LoxP
technology (58).
Vangl2 and nephron numbers
In mice, new nephrons continue to be generated during the
first week after birth (22,59). Non-viability of homozygous
Vangl2 mice due to severe NTDs precluded analyses of their
kidneys beyond the fetal period. Instead, we analysed
kidneys of Vangl2Lp/+ mice 4 weeks after birth. These
animals are overtly healthy although they have a deformity
consistent with their name, Looptail. Our data show that hap-
loinsufficiency of Vangl2 results in a modestly decreased
nephron number. Our method for quantifying glomerular
numbers relied on acid-mediated dissociation of the kidney
(60). While it is possible this method may be less accurate
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than stereology (61,62), any directional bias would be equal in
wild-type and Vangl2Lp/+ samples because the latter displayed
no tissue abnormalities such as cyst formation which might
affect the efficiency of dissociation. Because we demonstrated
that Vangl2Lp/+ as well as homozygous Vangl2 mice have a
branching defect, the reduction in final glomerular numbers
may be caused by a relative lack of branch tips available to
induce mesenchymal cells to differentiate into nephrons.
It is striking that human populations contain otherwise
healthy individuals with a very wide range of glomerular
numbers (1–2 million) per kidney (62). On the basis of
the results of animal experiments (60,61) and human studies
(63), it is likely that both environmental influences (e.g. the
diet a mother eats when pregnant) and genetic factors (e.g.
polymorphisms of genes expressed in the developing kidney)
together determine nephron number in an individual. More-
over, people with essential hypertension probably have a con-
genital nephron deficit (62) and animals born with too few
nephrons are prone to arterial hypertension later in life (61).
Further studies will be required to determine whether Looptail
mice are prone to hypertension or susceptible to glomerular
scarring as they age. However, we suggest that mutation or
variants of VANGL and other PCP genes should be considered
as possible causes of the variable glomerular numbers
observed in human kidneys.
MATERIALS AND METHODS
All reagents were obtained from Sigma Chemical (Poole, UK)
unless otherwise stated.
Histology and immunostaining
The Looptail mice (Jackson Laboratories, Bar Harbour, USA)
contain a point mutation which causes a serine to asparagine
transition at position 464 resulting in loss of Vangl2 function
(10,64). Mice were maintained on a C3H/HeH background.
Vangl2Lp homozygotes and heterozygotes were identified by
craniorachischisis and looped-tail phenotypes, respectively,
or genotyped using a pyrosequencing assay to amplify the
mutation directly (forward: 5′Biotin GTCCTGGCGCTTCAA
GAGGA; reverse: NNNGGCCAAACAGTGGACCTTGG;
sequence: CAGTGGACCTTGGTGA); wild-type littermates
were used as controls. Kidneys were fixed in 4% paraformal-
dehyde, dehydrated, wax-embedded and sectioned at 5 mm.
For some antibodies, 10 mm cryosections were used. In
some experiments, the following stains were used: PAS to
visualize all basement membranes and also proximal tubule
brush borders; haematoxylin to visualize nuclei; and eosin to
define cytoplasm. Immunohistochemistry was performed for
the following antibodies to: Celsr1 (gift from C. Formstone,
King’s College London), nephrin (Progen Biotechnik, Heidel-
berg, Germany), proliferating cell nuclear antigen (PCNA; BD
Biosciences, Oxford, UK), phospho-histone H3 (pH3; Milli-
pore, Dundee, UK), Cleaved caspase-3 (Cell Signalling
Technology, Danvers, MA, USA), rhodamine-conjugated
phalloidin (Invitrogen, Paisley, UK), Scrib (Santa Cruz Bio-
technology, USA), synaptopodin (Acris, Herford, Germany)
and WT-1 (Acris). Bound antibodies were detected with
either Alexa Fluor 488 or 594 secondary antibodies or appro-
priate horse-radish-conjugated antibodies followed by diami-
nobenzidine detection. Cell nuclei were visualized by
staining with 4′,6-diamidino-2-phenylindole (DAPI, HCl).
As negative controls, primary antibodies were omitted.
Explant culture and whole-mount metanephros staining
Freshly isolated metanephroi were collected from Vangl2Lp
homozygotes and wild-type littermates. Some metanephroi
were used immediately for staining but others were cultured
for up to 5 days as described (32). Metanephroi were fixed
and incubated with anti-pan-cytokeratin (Sigma) and/or
anti-WT1, followed by appropriate Alexa Fluor 488 or 594
secondary antibodies. Explants were imaged using confocal
microscopy and the number of tubules in each explant
counted.
Urine analysis
Twelve-week-old male Vangl2Lp heterozygote and wild-type
littermates were individually housed in metabolic cages for
24 h for urine collection. Urine concentration of albumin
(Exocell Incorporation, Philadelphia, PA, USA) and retinal-
binding protein-4 (Alpco Diagnostics, Salem, OR, USA)
were assessed using commercially available kits according
to the manufacturer’s protocols. All data were normalized to
urinary creatinine concentrations, measured by an Olympus
Au400 autoanalyser.
Glomerular morphology and counts
Glomerular morphology was assessed according to the follow-
ing categories: a, normal; b, only one or two capillary loops; c,
no capillary loops; d, abnormal. Glomeruli from E18.5 kidney
sections from wild-type, Vangl2Lp/+ and Vangl2Lp/Lp mice
were photographed and assigned to each category by an asses-
sor unaware of the genotypes. At least 100 glomeruli in each
of three kidneys from each of the three genotypes were
assessed. In individual kidneys, care was taken to use sections
at least 100 mm from each other to avoid counting the same
glomeruli more than once. For each kidney, the proportion
of glomeruli in each category was then calculated. Results
are expressed as a percentage of total glomeruli in each geno-
type. The same images were used to calculate glomerular tuft
diameters (which was taken as the maximum diameter of each
tuft). To measure the number of glomeruli in each kidney,
organs were removed from 4-week-old heterozygote
Vangl2Lp and wild-type male mice and placed in 0.1 M hydro-
chloric acid for 30 min at 378C. The acid was removed and
replaced with PBS and the tissue homogenized. Twenty lmi-
crolitres of this was pipetted into a haemacytometer and
using a 10× objective lens, the number of glomeruli in the
aliquot counted. This was repeated in triplicate for each
sample and the three results averaged to determine the
number of glomeruli in each sample and therefore each
kidney (65).
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Podocyte cell culture
Mouse podocytes (gift from Peter Mundel, University of
Miami, USA) (37) were cultured on tissue culture plastic
coated with 1% Matrigel substrate. For ongoing proliferation,
cells were cultured at 338C in a 5% CO2 incubator in RPMI
(Invitrogen) supplemented with 10% FCS (Invitrogen), anti-
biotics and interferon-g (10 U/ml). To induce differentiation,
cells were thermoshifted to 378C and cultured in RPMI in
the absence of interferon-g. Cells were allowed to differentiate
under these conditions for 7 days when they formed extensive
processes similar to their in vivo phenotype.
Quantitative RT–PCR
One mg of RNA was isolated from proliferating and differen-
tiating podocytes using TRI Reagent and cDNA prepared for
PCR of the PCP genes Celsr1, Fat4, Mpk1, Mpk2, Vangl1
and Vangl2 using previously described methods (66). To
assess differences in gene expression, quantitative real-time
RT–PCR was performed (66) on samples from three indepen-
dent experiments. All measurements were performed in dupli-
cate and HPRT was used as a housekeeping gene to allow
quantification. Alterations in gene expression in differentiated
cells were expressed relative to the mean intensity in undiffer-
entiated cells which was given a standardized value of 1. Nega-
tive controls of reactions without cDNA template were
included. Primer details are available on request.
Statistical methods
Data were analysed using either unpaired two-tailed t-tests, or
when more than two groups were analysed by one-way
ANOVA with least square difference correction. Significance
was accepted at P, 0.05; error bars in all data represent stan-
dard error mean.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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